Jonathan Maybaum

Web Publishing for the Individual, Not the Enterprise.

Jonathan Maybaum, 2004 .

Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells

Jonathan Maybaum, Daria M. Tanska, Theodore S Lawrence, 2009, Molecular Cancer Therapeutics.

Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

Jonathan Maybaum, Diane M Simeone, Theodore S Lawrence, 2010, Cancer research.

Bayesian Hierarchical Changepoint Methods in Modeling the Tumor Growth Profiles in Xenograft Experiments

Daniel Normolle, Jonathan Maybaum, Theodore S Lawrence, 2010, Clinical Cancer Research.